InvestorsHub Logo
Followers 7
Posts 234
Boards Moderated 0
Alias Born 08/18/2018

Re: None

Thursday, 04/22/2021 10:56:39 AM

Thursday, April 22, 2021 10:56:39 AM

Post# of 345830
Will probably never make it 100.



Cambrex Corporation is a Contract Development Manufacturing Organisation (CDMO) that provides drug substance, drug product and analytical services across the entire drug lifecycle, as well as active pharmaceutical ingredients (APIs).

Cambrex CorporationTypePrivateIndustryPharmaceuticalsFoundedNew Jersey (1981)HeadquartersEast Rutherford, NJ

Key people

Steven M. Klosk, CEO, President,Revenue? 534.7 million USD (2017)

Net income

? 57.2 million USD (2015)Total assets? 505.5 million USD (2015)Total equity? 310.8 million USD (2015)

Number of employees

2,100+Websitecambrex.com

Cambrex has cGMP manufacturing facilities in the US (Agawam, MA; Charles City, IA; Durham, NC; High Point, NC; Longmont, CO; Whippany, NJ), Canada (Mirabel, Québec) and Europe (Edinburgh, UK; Karlskoga, Sweden, Milan, Italy, and R&D centers in Tallinn, Estonia, Wiesbaden, Germany). The headquarters are located in East Rutherford, NJ.

In 2007, Cambrex divested their biologics business to Lonza to focus on small molecule APIs.[1]

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News